poisar

Stocks · News reference

L'Oréal and Walgreens Invest $27.5 Million in Shenzhen Boyin

Fiscal.ai

L'Oréal and Walgreens have led a $27.5 million funding round for the Chinese biotech firm Shenzhen Boyin to accelerate research and development.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading